Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INCYTE CORP Director's Dealing 2025

Sep 24, 2025

30371_dirs_2025-09-24_80200d12-c1c2-4692-a7df-cd917248294c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INCYTE CORP (INCY)
CIK: 0000879169
Period of Report: 2025-09-22

Reporting Person: Gardner David H (EVP, Chief Strategy Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-09-22 Common Stock A 9429 Acquired 9429 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-09-22 Performance Shares $ A 23573 Acquired 2028-09-22 Common Stock (23573) Direct
2025-09-22 Employee Stock Option (right to buy) $84.73 A 42899 Acquired 2035-09-22 Common Stock (42899) Direct

Footnotes

F1: Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis.

F2: Includes the September 22, 2025 aggregate grant of 9,429 shares of common stock.

F3: Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer.

F4: The September 22, 2025 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.